Enquiry form for Idiopathic Pulmonary Fibrosis (IPF)

24-502 Part C – people with IPF

Participants with idiopathic pulmonary fibrosis (IPF) needed for the study of a potential new medicine to treat progressive multiple sclerosis and IPF. You must be aged 25 to 65, with a BMI between 18 and 30.9. Women must be post-menopausal for at least 1 year or surgically sterilised. This study involves 1 screening visit, up to 6 nights’ residence on our ward and 2 outpatient visits. You’ll have a total of 3 PET scans. Starts 4 March 2025.

Receive up to £4,750 + reasonable travel expenses.

This form is for people with IPF. By participating in one of our trials, you’ll be helping to advance medical research and improve human health.